| | Class 2 Device Recall 10Fore Hemostasis Valve |  |
| Date Initiated by Firm | July 25, 2025 |
| Date Posted | September 11, 2025 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-2553-2025 |
| Recall Event ID |
97420 |
| Product Classification |
Adaptor, stopcock, manifold, fitting, cardiopulmonary bypass - Product Code DTL
|
| Product | 10Fore Hemostasis Valve
Catalog Number / UDI-DI code:
MAPTEN4 / 00884450821305
MAPTEN42 / 00884450832509
MAPTEN452 / 00884450821329
The 10Fore Hemostasis Valve is intended to maintain hemostasis during the
introduction/withdrawal and use of diagnostic and interventional devices. |
| Code Information |
Catalog Number / UDI-DI code:
MAPTEN4 / 00884450821305
Lot Numbers:
H3098831
H3111155
H3152503
H3155611
H3186901
MAPTEN42 / 00884450832509
Lot Numbers:
H3076189
H3111156
H3152504
H3155614
H3173674
MAPTEN452 / 00884450821329
Lot Number:
H3111162
|
Recalling Firm/ Manufacturer |
Merit Medical Systems, Inc. 1600 W Merit Pkwy South Jordan UT 84095-2416
|
| For Additional Information Contact | Ms. Hannah Gay 801-432-2786 |
Manufacturer Reason for Recall | Due to a manufacturing issue involving the silicone quad ring where the ring is deformed or otherwise damaged and may cause a foreign body in the fluid pathway. |
FDA Determined Cause 2 | Employee error |
| Action | On 07/23/2025, the firm emailed an "URGENT MEDICAL DEVICE RECALL NOTICE" to customers informing them that due to a manufacturing defect. Specifically, the o-ring between the y-body and the rotator may be damaged during assembly and a portion of the o-ring may remain loose or detach. Use of the affected product may result in a foreign body in the fluid path.
Customer are instructed to:
Immediately stop using or distributing the affected lots and return to Merit.
1. Please immediately determine if any of the devices identified in the attached Customer Response Form (CRF) are within your facility, quarantine them, and discontinue use and distribution.
2. Ensure that applicable personnel within your organization are made aware of this field action.
3. If the product has been further distributed to other facilities, institutions, or manufacturers, please ensure this notice is immediately shared with them and note the quantity distributed on the CRF.
Additional distribution details may be required by health authorities.
4. Please fill out, scan and email the completed Customer Response Form to Customer Service at response@merit.com within 10 business days. All affected product shipped to you must be accounted for on the CRF.
5. Please immediately return all affected lots in your possession to Merit, per the instructions in the attached CRF.
Any questions concerning this communication, contact your Merit Sales Representative or Merit Customer Service via email at RESPONSE@merit.com or via phone at +1 800 356 3748 | Hours: 6 am to 6 pm MST | Mon-Fri. |
| Quantity in Commerce | 447 |
| Distribution | Worldwide - U.S. Nationwide distribution in the states of CA, FL, LA, MT, NY, SD, and WI. The countries of Canada and Korea |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
|
|
|